Cargando…
Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction
Cyclosporine A (CsA) is an immunosuppressant agent and is utilized as a second-line drug therapy for refractory nephrotic syndrome (RNS). In general, the use of CsA is strictly controlled in patients with an estimated glomerular filtration rate (eGFR) <30–40 ml/min/1.73 m(2), and little is known...
Autores principales: | GAO, XIANG, MA, YIYI, SUN, LIJUN, CHEN, DONGPING, MEI, CHANGLIN, XU, CHENGGANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881069/ https://www.ncbi.nlm.nih.gov/pubmed/24396423 http://dx.doi.org/10.3892/etm.2013.1446 |
Ejemplares similares
-
Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults
por: Xie, Guoqiang, et al.
Publicado: (2012) -
Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome
por: Iyengar, A., et al.
Publicado: (2013) -
Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
por: Yu, Xiaojuan, et al.
Publicado: (2017) -
Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children
por: Nikibakhsh, A. A., et al.
Publicado: (2011) -
Breastfeeding by a mother taking cyclosporine for nephrotic syndrome
por: Li, Ruizhe, et al.
Publicado: (2022)